Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02260661 |
| Title | Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | AstraZeneca |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Denver | Colorado | United States | Details | ||
| Research Site | Greenville | South Carolina | United States | Details | ||
| Research Site | Nashville | Tennessee | United States | Details | ||
| Research Site | Houston | Texas | United States | Details | ||
| Research Site | Milwaukee | Wisconsin | United States | Details | ||
| Research Site | Cambridge | United Kingdom | Details | |||
| Sarah Cannon Research Institute, United Kingdom | London | W1G 6AD | United Kingdom | Details | ||
| Research Site | London | United Kingdom | Details | |||
| Research Site | Manchester | United Kingdom | Details |